Safety Alerts & Recalls

Alerts for Dronedarone

Title Date Published Source
FDA Completes Safety Review of Multaq and Updates Prescribing Information 2011-12-19
Sanofi-Aventis informiert über Anwendungsbeschränkungen und Warnehinweise bei Dronedaron (Multaq) 2011-10-27
L’AFSSAPS informe les professionnels de santé sur les nouvelles restrictions d’utilisation et les mises en gardes à prendre en compte avec le médicament MULTAQ (dronédarone) 2011-10-26
MHRA Recommends Restricted Prescribing of Multaq Due to Safety Concerns 2011-10-18
La Agencia Europea De Medicamentos Recomienda Restringir El Uso De Multaq 2011-09-29
Prescribers Reminded: Use Multaq (Dronedarone) Only for Recommended Indications 2011-08-05
La EMA Revisa El Balance Beneficio-Riesgo De Multaq (Dronedarona) 2011-07-26
Sanofi-Aventis beendet Studie mit dem Medikament Dronedaron wegen schwerer aufgetretener Nebenwirkungen vorzeitig 2011-07-22
FDA Reviewing Results of Study Multaq (Dronedarone) in Patients with Permanent Atrial Fibrillation 2011-07-22
Le laboratoire SANOFI arrête un essai clinique portant sur le médicament Multaq (dronédarone) suite à la survenue d’effets indésirables cardiovasculaires sévères 2011-07-14
Posible Riesgo de Daño al Hígado Grave con Dronedarona (Multaq) 2011-02-21
Hersteller und Behoerden informieren AErzte ueber schwere Leberschaeden in Zusammenhang mit einem neuen Herzmedikament 2011-01-25
Possible Risk of Severe Liver Injury with Dronedarone (Multaq) 2011-01-24
The FDA Warns About Possible Risk of Severe Liver Injury with Dronedarone (Multaq) 2011-01-16
See alerts for all drugs
Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.